Otizm Spektrum Bozukluğu ve Dikkat Eksikliği Hiperaktivite Bozukluğu: Tanı ve Tedavi

Jensen CM, Steinhausen H-C. Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. ADHD Attention Deficit and Hyperactivity Disorders. 2015;7:27-38.

Antshel KM, Zhang-James Y, Faraone SV. The comorbidity of ADHD and autism spectrum disorder. Expert Rev Neurother. 2013;13(10):1117-28.

Cooper M, Martin J, Langley K, Hamshere M, Thapar A. Autistic traits in children with ADHD index clinical and cognitive problems. European child & adolescent psychiatry. 2014;23:23-34.

Brieber S, Neufang S, Bruning N, Kamp‐Becker I, Remschmidt H, Herpertz‐Dahlmann B, et al. Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry. 2007;48(12):1251-8.

Clark T, Feehan C, Tinline C, Vostanis P. Autistic symptoms in children with attention deficit-hyperactivity disorder. European child & adolescent psychiatry. 1999;8(1):50-5.

Ghirardi L, Brikell I, Kuja-Halkola R, Freitag CM, Franke B, Asherson P, et al. The familial co-aggregation of ASD and ADHD: a register-based cohort study. Molecular psychiatry. 2018;23(2):257-62.

Ghirardi L, Pettersson E, Taylor MJ, Freitag CM, Franke B, Asherson P, et al. Genetic and environmental contribution to the overlap between ADHD and ASD trait dimensions in young adults: a twin study. Psychological medicine. 2019;49(10):1713-21.

Musser ED, Hawkey E, Kachan‐Liu SS, Lees P, Roullet JB, Goddard K, et al. Shared familial transmission of autism spectrum and attention‐deficit/hyperactivity disorders. Journal of Child Psychology and Psychiatry. 2014;55(7):819-27.

Jokiranta-Olkoniemi E, Cheslack-Postava K, Sucksdorff D, Suominen A, Gyllenberg D, Chudal R, et al. Risk of psychiatric and neurodevelopmental disorders among siblings of probands with autism spectrum disorders. JAMA psychiatry. 2016;73(6):622-9.

Rommelse NN, Altink ME, Fliers EA, Martin NC, Buschgens CJ, Hartman CA, et al. Comorbid problems in ADHD: degree of association, shared endophenotypes, and formation of distinct subtypes. Implications for a future DSM. J Abnorm Child Psychol. 2009;37:793-804.

Smalley SL, Kustanovich V, Minassian SL, Stone JL, Ogdie MN, McGough JJ, et al. Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. The American Journal of Human Genetics. 2002;71(4):959-63.

Hale TS, Hariri AR, McCracken JT. Attention‐deficit/hyperactivity disorder: Perspectives from neuroimaging. Mental retardation and developmental disabilities research reviews. 2000;6(3):214-9.

Eliez S, Reiss AL. Annotation: MRI neuroimaging of childhood psychiatric disorders: a selective review. The Journal of Child Psychology and Psychiatry and Allied Disciplines. 2000;41(6):679-94.

Geurts HM, Verté S, Oosterlaan J, Roeyers H, Sergeant JA. How specific are executive functioning deficits in attention deficit hyperactivity disorder and autism? Journal of child psychology and psychiatry. 2004;45(4):836-54.

Craig F, Margari F, Legrottaglie AR, Palumbi R, De Giambattista C, Margari L. A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder. Neuropsychiatric disease and treatment. 2016:1191-202.

Happé F, Booth R, Charlton R, Hughes C. Executive function deficits in autism spectrum disorders and attention-deficit/hyperactivity disorder: examining profiles across domains and ages. Brain and cognition. 2006;61(1):25-39.

Kilincaslan A, Mukaddes NM, Küçükyazici GS, Gürvit H. Assessment of executive/attentional performance in Asperger's disorder. Turk Psikiyatri Dergisi. 2010;21(4):289.

Smith T, Iadarola S. Evidence base update for autism spectrum disorder. Journal of Clinical Child & Adolescent Psychology. 2015;44(6):897-922.

Goode AP, Coeytaux RR, Maslow GR, Davis N, Hill S, Namdari B, et al. Nonpharmacologic treatments for attention-deficit/hyperactivity disorder: a systematic review. Pediatrics. 2018;141(6).

Caye A, Swanson JM, Coghill D, Rohde LA. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Molecular psychiatry. 2019;24(3):390-408.

Gagliardi L, Rusconi F, Bellù R, Zanini R, Network IN. Association of maternal hypertension and chorioamnionitis with preterm outcomes. Pediatrics. 2014;134(1):e154-e61.

Mansour R, Dovi AT, Lane DM, Loveland KA, Pearson DA. ADHD severity as it relates to comorbid psychiatric symptomatology in children with Autism Spectrum Disorders (ASD). Research in developmental disabilities. 2017;60:52-64.

Kamimura-Nishimura K, Froehlich T, Chirdkiatgumchai V, Adams R, Fredstrom B, Manning P. Autism spectrum disorders and their treatment with psychotropic medications in a nationally representative outpatient sample: 1994–2009. Annals of epidemiology. 2017;27(7):448-53. e1.

Yamamuro K, Tsujii N, Ota T, Kishimoto T, Iida J. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention‐deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists. Psychiatry and Clinical Neurosciences. 2017;71(8):554-61.

Canadian A. Resource Alliance (CADDRA): Canadian ADHD Practice Guidelines. Toronto: CADDRA. 2018.

Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. European child & adolescent psychiatry. 2010;19:353-64.

Ercan E. Türkiye DEHB uzman görüşü raporu: Dikkat eksikliği hiperaktivite bozukluğu uzman görüşü raporu. Türkiye; 2013.

Reichow B, Volkmar FR, Bloch MH. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders. Journal of autism and developmental disorders. 2013;43:2435-41.

Sturman N, Deckx L, van Driel ML. Methylphenidate for children and adolescents with autism spectrum disorder. Cochrane Database of Systematic Reviews. 2017(11).

Hollway JA, Mendoza-Burcham M, Andridge R, Aman MG, Handen B, Arnold LE, et al. Atomoxetine, parent training, and their effects on sleep in youth with autism spectrum disorder and attention-deficit/hyperactivity disorder. Journal of child and adolescent psychopharmacology. 2018;28(2):130-5.

Medicines N, UK PC. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. 2015.

Arnold LE, Ober N, Aman MG, Handen B, Smith T, Pan X, et al. A 1.5-year follow-up of parent training and atomoxetine for attention-deficit/hyperactivity disorder symptoms and noncompliant/disruptive behavior in autism. Journal of child and adolescent psychopharmacology. 2018;28(5):322-30.

Mahajan R, Bernal MP, Panzer R, Whitaker A, Roberts W, Handen B, et al. Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders. Pediatrics. 2012;130(Supplement_2):S125-S38.